Found 2,113 results
By Jon D. Markman On August 1, 201804:59 PM Eastern
Big Pharma is in a rut. The industry keeps spending more and yet making fewer scientific breakthroughs.
But help is on the way.
Last week, GlaxoSmithKline (GSK) announced a radical change in...
By Jon D. Markman On April 30, 201807:55 AM Eastern
Martin wanted to share this article from Jon D. Markman — he's our technology options investing expert and has some important information to share with you about healthcare. If you'd like to read...
By Jon D. Markman On April 13, 201803:40 PM Eastern
I have a theory. It is controversial because it involves Apple (AAPL).
But even if you’re addicted to your iPhone or MacBook — or the stock’s double- and even triple-digit yearly returns — I...
By Gavin Magor On December 19, 201708:27 AM Eastern
The Federal Reserve just made its third interest rate hike this year, and the fifth since our long, slow recovery began back in 2009 (Seems like yesterday, but that was eight years ago!) More...
By Jon D. Markman On October 27, 201702:00 PM Eastern
Thirteen weeks into her pregnancy, Lexi Royer discovered the baby growing inside her had a serious birth defect. Then something amazing happened …
Two days into the 25th week of her term,...
By Jon D. Markman On October 9, 201702:00 PM Eastern
Every year, some of the smartest people on Wall Street get together to hobnob, raise money for charity and talk about their very best ideas.
This year, Dallas hosted the Great Investors Best...
By Mandeep Rai On April 26, 201707:50 AM Eastern
I want to start today’s column by showing you four charts – each of which illustrates the results from a different investment strategy. The red line in these charts shows the back-tested results...
By The Weiss Ratings Team On June 27, 201610:26 AM Eastern
Global markets were taken by surprise on Friday when the votes were counted in the U.K., as it became clear that Britain was going to leave the European Union (EU) after more than 40 years. Many,...
By Martin D. Weiss, Ph.D. On December 2, 201912:23 PM Eastern
It’s a scam that few advisers talk about and most investors don’t even think about: The conflicts, bias, payola and cover-ups behind most of the ratings you get from Wall Street.
I’m talking...
By The Weiss Ratings Team On August 1, 201612:46 PM Eastern
With Exxon and Chevron reporting disappointing results on Friday, and considering the general malaise in the energy sector, surely there must be some stocks that fit the criteria for safe longer...